Versant Venture Management, LLC Repare Therapeutics Inc. Transaction History
Versant Venture Management, LLC
- $48 Million
- Q1 2025
A detailed history of Versant Venture Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,646,657 shares of RPTX stock, worth $3.49 Million. This represents 5.46% of its overall portfolio holdings.
Number of Shares
2,646,657
Previous 2,646,657
-0.0%
Holding current value
$3.49 Million
Previous $3.47 Million
24.43%
% of portfolio
5.46%
Previous 5.13%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
54Shares Held
32.5MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$13.6 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.55 Million1.76% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.39 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.92 Million17.66% of portfolio
-
Redmile Group, LLC San Francisco, CA1.88MShares$2.49 Million0.2% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $55.4M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...